Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#ANDA083667 ×

Actualizaciones regulatorias

25 sept 2026•1 min de lectura

FDA Discontinues Testosterone Enanthate Injectable Products (ANDA083667)

The FDA has discontinued two injectable testosterone enanthate products from Watson Labs, listed under ANDA083667.